Sinopharm Group (SHTDY) Short Interest Ratio & Short Volume $11.62 -0.08 (-0.68%) As of 05/1/2025 03:26 PM Eastern Add Compare Share Share Short Interest Stock AnalysisChartDividendHeadlinesShort InterestBuy This Stock Sinopharm Group Short Interest DataSinopharm Group (SHTDY) has a short interest of 3,600 shares. This marks a 3,500.00% increase in short interest from the previous month. The short interest ratio (days to cover) is 0.1, indicating that it would take 0.1 days of the average trading volume of 18,574 shares to cover all short positions.Current Short Interest3,600 sharesPrevious Short Interest100 sharesChange Vs. Previous Month+3,500.00%Dollar Volume Sold Short$41,400.00Short Interest Ratio0.1 Days to CoverLast Record DateApril 15, 2025Today's Trading Volume6,898 sharesAverage Trading Volume18,574 sharesToday's Volume Vs. Average37% Short Selling Sinopharm Group? Sign up to receive the latest short interest report for Sinopharm Group and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartSHTDY Short Interest Over TimeSHTDY Days to Cover Over TimeSHTDY Percentage of Float Shorted Over Time Sinopharm Group Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/20253,600 shares $41,400.00 +3,500.0%N/A0.1 $11.50 3/31/2025100 shares $1,157.00 -96.3%N/A0 $11.57 3/15/20252,700 shares $33,979.50 -40.0%N/A0.1 $12.59 2/28/20254,500 shares $55,125.00 -26.2%N/A0.2 $12.25 2/15/20256,100 shares $77,592.00 +79.4%N/A0.2 $12.72 1/31/20253,400 shares $45,016.00 -84.4%N/A0.1 $13.24 1/15/202521,800 shares $281,874.00 +113.7%N/A0.6 $12.93 12/31/202410,200 shares $138,414.00 +2.0%N/A0.5 $13.57 12/15/202410,000 shares $140,260.00 +56.3%N/A0.4 $14.03 11/30/20246,400 shares $86,598.40 +6.7%N/A0.3 $13.53 Get the Latest News and Ratings for SHTDY and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Sinopharm Group and its competitors with MarketBeat's FREE daily newsletter. 11/15/20246,000 shares $77,940.00 -90.5%N/A0.2 $12.99 10/31/202463,200 shares $785,260.00 +305.1%N/A0.8 $12.43 10/15/202415,600 shares $195,234.00 +642.9%N/A0.7 $12.52 9/30/20242,100 shares $27,520.50 +2,000.0%N/A0 $13.11 9/15/2024100 shares $1,061.00 -97.6%N/A0 $10.61 8/31/20244,200 shares $48,472.20 +1,300.0%N/A0.2 $11.54 8/15/2024300 shares $3,805.65 +200.0%N/A0 $12.69 7/31/2024100 shares $1,161.00 -66.7%N/A0 $11.61 7/15/2024300 shares $3,705.00 +50.0%N/A0 $12.35 6/30/2024200 shares $2,646.00 -89.5%N/A0 $13.23 6/15/20241,900 shares $26,531.60 +46.2%N/A0.1 $13.96 5/31/20241,300 shares $17,654.00 -93.7%N/A0.1 $13.58 5/15/202420,700 shares $299,943.00 -17.2%N/A1.2 $14.49 4/30/202425,000 shares $313,500.00 +7.8%N/A1.1 $12.54 4/15/202423,200 shares $288,202.00 -22.4%N/A1.2 $12.42 3/31/202429,900 shares $382,421.00 +33.5%N/A1.7 $12.79 3/15/202422,400 shares $296,340.80 +2.3%N/A1.7 $13.23 2/29/202421,900 shares $304,519.50 +356.3%N/A0.9 $13.91 2/15/20244,800 shares $63,336.00 -66.7%N/A0.1 $13.20 1/15/202493,500 shares $1.22 million +15.7%N/A3.1 $13.03 12/31/202380,800 shares $1.05 million +49.1%N/A1.1 $13.05 12/15/202354,200 shares $662,324.00 +100.0%N/A1.3 $12.22 11/30/202327,100 shares $333,601.00 -44.6%N/A0.3 $12.31 11/15/202348,900 shares $615,651.00 +0.8%N/A1.8 $12.59 10/31/202348,500 shares $574,725.00 -23.1%N/A1.4 $11.85 10/15/202363,100 shares $891,129.75 -8.6%N/A3 $14.12 9/30/202369,000 shares $1.00 million +1.6%N/A2.4 $14.52 9/15/202367,900 shares $943,810.00 +9.5%N/A2.8 $13.90 8/31/202362,000 shares $901,480.00 +166.1%N/A1.4 $14.54 8/15/202323,300 shares $312,220.00 +47.5%N/A0.8 $13.40Trump’s treachery (Ad)Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.Millions of Americans are about to be wiped out, while others could make a fortune… click here to ma 7/31/202315,800 shares $247,546.50 -21.4%N/A0.6 $15.67 7/15/202320,100 shares $299,590.50 +9.8%N/A0.9 $14.91 6/30/202318,300 shares $284,565.00 +120.5%N/A0.6 $15.55 6/15/20238,300 shares $135,207.00 No ChangeN/A0.1 $16.29 5/15/20232,300 shares $38,916.00 -45.2%N/A0.1 $16.92 4/30/20234,200 shares $73,542.00 -30.0%N/A0.3 $17.51 4/15/20236,000 shares $94,140.00 +81.8%N/A0.3 $15.69 3/31/20233,300 shares $49,137.00 -84.9%N/A0 $14.89 3/15/202321,900 shares $301,125.00 +90.4%N/A1.1 $13.75 2/28/202311,500 shares $153,697.50 +62.0%N/A0.9 $13.37 2/15/20237,100 shares $97,270.00 -78.1%N/A0.3 $13.70 1/31/202332,400 shares $393,984.00 +14.5%N/A1.6 $12.16 1/15/202328,300 shares $364,787.00 +126.4%N/A0.7 $12.89 12/30/202212,500 shares $157,375.00 -40.2%N/A0.4 $12.59 12/15/202220,900 shares $270,655.00 +194.4%N/A0.5 $12.95 11/30/20227,100 shares $83,993.00 -43.7%N/A0.2 $11.83 11/15/202212,600 shares $137,970.00 -76.8%N/A0.1 $10.95 10/31/202254,300 shares $512,592.00 +1,408.3%N/A0.5 $9.44 10/15/20223,600 shares $36,396.00 +20.0%N/A0 $10.11 9/30/20223,000 shares $29,730.00 +328.6%N/A0 $9.91 9/15/2022700 shares $7,105.00 -91.3%N/A0 $10.15 8/31/20228,000 shares $88,560.00 -51.2%N/A0.1 $11.07 8/15/202216,400 shares $181,220.00 +2,242.9%N/A0.3 $11.05 7/31/2022700 shares $8,015.00 -92.2%N/A0 $11.45 7/15/20229,000 shares $106,560.00 -62.3%N/A0.2 $11.84 6/30/202223,900 shares $288,712.00 +23,800.0%N/A0.4 $12.08 6/15/2022100 shares $1,160.00 -93.3%N/A0 $11.60 5/31/20221,500 shares $18,390.00 -6.3%N/A0 $12.26 5/15/20221,600 shares $18,496.00 -5.9%N/A0 $11.56 4/30/20221,700 shares $19,286.50 -51.4%N/A0 $11.35 4/15/20223,500 shares $38,675.00 -70.1%N/A0.1 $11.05 3/31/202211,700 shares $132,151.50 +4.5%N/A0.2 $11.30 3/15/202211,200 shares $119,728.00 +100.0%N/A0.1 $10.69 2/28/20225,600 shares $68,040.00 -3.5%N/A0.1 $12.15 2/15/20225,800 shares $71,688.00 -94.5%N/A0.1 $12.36 1/31/2022105,500 shares $1.19 million -27.1%N/A0.8 $11.28 1/15/2022144,700 shares $1.70 million +460.9%N/A0.8 $11.73 12/31/202125,800 shares $278,898.00 No ChangeN/A0.2 $10.81 11/30/20211,900 shares $20,501.00 -83.6%N/A0 $10.79 11/15/202111,600 shares $131,776.00 +866.7%N/A0.2 $11.36 10/29/20211,200 shares $14,196.00 -88.2%N/A0 $11.83 10/15/202110,200 shares $137,190.00 +292.3%N/A0.2 $13.45 9/30/20212,600 shares $33,845.50 +30.0%N/A0.1 $13.02 9/15/20212,000 shares $26,260.00 -73.0%N/A0 $13.13 8/31/20217,400 shares $94,350.00 -23.7%N/A0.2 $12.75 8/13/20219,700 shares $131,629.00 +76.4%N/A0.3 $13.57 7/30/20215,500 shares $71,995.00 -42.7%N/A0.1 $13.09 7/15/20219,600 shares $139,296.96 +585.7%N/A0.2 $14.51 6/30/20211,400 shares $20,874.00 -50.0%N/A0 $14.91 6/15/20212,800 shares $42,868.00 +27.3%N/A0.1 $15.31Trump’s treachery (Ad)Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.Millions of Americans are about to be wiped out, while others could make a fortune… click here to ma 5/28/20212,200 shares $36,608.00 -91.7%N/A0.1 $16.64 5/14/202126,600 shares $424,270.00 +6,550.0%N/A0.4 $15.95 4/30/2021400 shares $6,140.00 -88.2%N/A0 $15.35 4/15/20213,400 shares $45,084.00 +3,300.0%N/A0 $13.26 3/31/2021100 shares $1,213.00 No ChangeN/A0 $12.13 2/26/20217,400 shares $87,838.00 +516.7%N/A0.1 $11.87 2/12/20211,200 shares $14,767.68 -60.0%N/A0 $12.31 1/29/20213,000 shares $37,650.00 -91.5%N/A0 $12.55 1/15/202117,400 shares $207,582.00 -4.9%N/A0.2 $11.93 12/31/202014,600 shares $171,842.00 -16.1%N/A0.1 $11.77 12/15/202017,400 shares $211,758.00 -4.9%N/A0.2 $12.17 11/30/202018,300 shares $232,410.00 +110.3%N/A0.3 $12.70 11/15/20208,700 shares $106,401.00 No ChangeN/A0.2 $12.23 10/15/202021,900 shares $236,082.00 +30.4%N/A0.6 $10.78 9/30/202016,800 shares $177,408.00 +16,700.0%N/A0.5 $10.56 9/15/2020100 shares $1,213.00 -99.5%N/A0 $12.13 8/31/202021,100 shares $259,952.00 +3,416.7%N/A0.4 $12.32 8/14/2020600 shares $7,245.60 +500.0%N/A0 $12.08 7/31/2020100 shares $1,180.50 -97.6%N/A0 $11.81 7/15/20204,100 shares $50,758.00 +127.8%N/A0.1 $12.38 6/30/20201,800 shares $22,806.00 +350.0%N/A0 $12.67 6/15/2020400 shares $4,872.00 +33.3%N/A0 $12.18 5/29/2020300 shares $3,674.25 -40.0%N/A0 $12.25 5/15/2020500 shares $6,135.00 -97.1%N/A0 $12.27 SHTDY Short Interest - Frequently Asked Questions What is Sinopharm Group's current short interest? Short interest is the volume of Sinopharm Group shares that have been sold short but have not yet been covered or closed out. As of April 15th, traders have sold 3,600 shares of SHTDY short. Learn More on Sinopharm Group's current short interest. Is Sinopharm Group's short interest increasing or decreasing? Sinopharm Group saw a increase in short interest in the month of April. As of April 15th, there was short interest totaling 3,600 shares, an increase of 3,500.0% from the previous total of 100 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Sinopharm Group's short interest compare to its competitors? Here is how the short interest of companies in the industry of "personal services" compare to Sinopharm Group: Roche Holding AG (0.07%). Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($21.71 billion), iShares 20+ Year Treasury Bond ETF ($9.48 billion), Strategy Incorporated ($8.92 billion), Charter Communications, Inc. ($3.86 billion), Apollo Global Management, Inc. ($3.86 billion), Capital One Financial Co. ($3.72 billion), Super Micro Computer, Inc. ($3.47 billion), AppLovin Co. ($2.64 billion), VanEck Semiconductor ETF ($2.46 billion), and The Kroger Co. ($2.33 billion). View all of the most shorted stocks. What does it mean to sell short Sinopharm Group stock? Short selling SHTDY is an investing strategy that aims to generate trading profit from Sinopharm Group as its price is falling. SHTDY shares are trading down $0.08 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Sinopharm Group? A short squeeze for Sinopharm Group occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of SHTDY, which in turn drives the price of the stock up even further. How often is Sinopharm Group's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including SHTDY, twice per month. The most recent reporting period available is April, 15 2025. More Short Interest Resources from MarketBeat Related Companies Aalberts Short Interest Data Absa Group Short Interest Data Air China Short Interest Data Airbus Short Interest Data Airports of Thailand Public Short Interest Data Akbank T.A.S. Short Interest Data Amada Short Interest Data Anadolu Efes Biracilik ve Malt Sanayii Anonim Sirketi Short Interest Data Asia Broadband Short Interest Data ATEX Resources Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:SHTDY) was last updated on 5/2/2025 by MarketBeat.com Staff From Our PartnersDOGE officially begins retirement transformationElon Musk's Department of Government Efficiency ("DOGE") just announced the first-ever "fully digital retireme...Altimetry | SponsoredElon just did WHAT!?As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they got...Brownstone Research | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredJames Altucher: Do not invest in AI unless…I made millions during the crypto boom. Many “experts” are now saying… Artificial Intelligence opportuni...Paradigm Press | SponsoredWhat President Trump’s Executive Order 14154 means for your moneyNearly $3 trillion disappeared from the stock market on Thursday morning. According to Whitney Tilson - a f...Stansberry Research | SponsoredMusk's warning signal: Prepare before the cascade beginsWhen Elon Musk triggered his AI layoff plan, most analysts missed what it really meant. Louis Navellier didn’t...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sinopharm Group Co. Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sinopharm Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy SHTDY Stock Free SHTDY Stock Alerts